New 1H‐indole‐2,3‐dione 3‐thiosemicarbazones with 3‐sulfamoylphenyl moiety as selective carbonic anhydrase inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202200023
- By:
- Publication type:
- Article
Works matching IS 03656233 AND DT 2022 AND VI 355 AND IP 8
Results: 16
1
2
Editorial Board: Arch Pharm (8/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202270018
- Publication type:
- Article
3
Exploring ibuprofen derivatives as α‐glucosidase and lipoxygenase inhibitors: Cytotoxicity and in silico studies.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202200013
- By:
- Publication type:
- Article
4
Cover Picture: Arch Pharm (8/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202270017
- Publication type:
- Article
5
Design, synthesis, and biological activity of novel dithiocarbamate‐methylsulfonyl hybrids as carbonic anhydrase inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202200132
- By:
- Publication type:
- Article
6
2,2,2‐Trifluoroethanol‐mediated hydroarylation of fluorinated alkynes with indoles: Application to diindolylmethanes.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202100488
- By:
- Publication type:
- Article
7
ω‐(5‐Phenyl‐2H‐tetrazol‐2‐yl)alkyl‐substituted hydrazides and related compounds as inhibitors of amine oxidase copper containing 3 (AOC3).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202200111
- By:
- Publication type:
- Article
8
Safe and selective anticancer agents from tetrafluorinated azobenzene‐imidazolium ionic liquids: Synthesis, characterization, and cytotoxic effects.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202200085
- By:
- Publication type:
- Article
9
The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202200086
- By:
- Publication type:
- Article
10
Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase‐B inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202200084
- By:
- Publication type:
- Article
11
Selective cytotoxicity of ent‐kaurene diterpenoids isolated from Baccharis lateralis and Baccharis retusa (Asteraceae).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202200083
- By:
- Publication type:
- Article
12
Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202200082
- By:
- Publication type:
- Article
13
Anti‐inflammatory activity of pyridazinones: A review.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202200067
- By:
- Publication type:
- Article
14
Identification of 9H‐purin‐6‐amine derivatives as novel aldose reductase inhibitors for the treatment of diabetic complications.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202200043
- By:
- Publication type:
- Article
15
Design, synthesis, SAR, and biological evaluation of saccharin‐based hybrids as carbonic anhydrase inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202200019
- By:
- Publication type:
- Article
16
Quinoxaline‐based efflux pump inhibitors restore drug susceptibility in drug‐resistant nontuberculous mycobacteria.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 8, p. 1, doi. 10.1002/ardp.202100492
- By:
- Publication type:
- Article